Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Haematology"
DOI: 10.1111/ejh.13755
Abstract: Molecular biomarker tests can inform the clinical management of genomic heterogeneous hematological malignancies, yet their availability in routine care largely depends on the supporting health economic evidence. This study aims to systematically review the economic… read more here.
Keywords: molecular biomarker; biomarker tests; hematological malignancies; economic evidence ... See more keywords
Economic and Diagnostic Biomarker Tests of Neonatal Sepsis: A Prospective Study from a Tertiary Care Hospital in a Low-Income Country
Sign Up to like & getrecommendations! Published in 2022 at "BioMed Research International"
DOI: 10.1155/2022/5166380
Abstract: Background Neonatal sepsis is a leading cause of morbidity and mortality in low-and middle-income countries (LMICs). There are several sophisticated biomarkers; however, they are still insufficient in precision. In this perspective, our study aims to… read more here.
Keywords: sepsis; biomarker; neonatal sepsis; biomarker tests ... See more keywords
The use of molecular biomarker tests: an interview study with healthcare providers about a molecular biomarker test for prostate cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Personalized medicine"
DOI: 10.2217/pme-2020-0156
Abstract: Aim: Investigate why healthcare providers are not always willing to use molecular biomarker tests, even though they promise to personalize disease diagnosis and treatment. Materials & methods: We interviewed 20 Dutch urological healthcare providers to… read more here.
Keywords: molecular biomarker; healthcare providers; use; biomarker ... See more keywords